 | • レポートコード：B-GIR09F3553 • 出版社/出版日：GlobalInfoResearch / 2019年9月13日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、シムリン（プラムリンチド）の世界市場について調べ、まとめました。種類別セグメントは、1.5mlペンインジェクター、2.7mlペンインジェクター等、用途別セグメントは、I型糖尿病、II型糖尿病等に区分しました。シムリン（プラムリンチド）の世界市場概観、企業動向、企業別シムリン（プラムリンチド）シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・シムリン（プラムリンチド）の市場概観 ・シムリン（プラムリンチド）の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・シムリン（プラムリンチド）の企業別販売動向、市場シェア、市場集中度、競争動向 ・シムリン（プラムリンチド）の世界市場規模 ・シムリン（プラムリンチド）の北米市場分析（アメリカ、カナダ、メキシコ等） ・シムリン（プラムリンチド）のアメリカ市場規模推移 ・シムリン（プラムリンチド）のカナダ市場規模推移 ・シムリン（プラムリンチド）のメキシコ市場規模推移 ・シムリン（プラムリンチド）のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・シムリン（プラムリンチド）のドイツ市場規模推移 ・シムリン（プラムリンチド）のイギリス市場規模推移 ・シムリン（プラムリンチド）のロシア市場規模推移 ・シムリン（プラムリンチド）のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・シムリン（プラムリンチド）の日本市場規模推移 ・シムリン（プラムリンチド）の中国市場規模推移 ・シムリン（プラムリンチド）の韓国市場規模推移 ・シムリン（プラムリンチド）のインド市場規模推移 ・シムリン（プラムリンチド）の東南アジア市場規模推移 ・シムリン（プラムリンチド）の南米市場分析（ブラジル、アルゼンチン等） ・シムリン（プラムリンチド）の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・シムリン（プラムリンチド）の種類別分析/販売量、売上、市場シェア（1.5mlペンインジェクター、2.7mlペンインジェクター） ・シムリン（プラムリンチド）の用途別分析/市場規模（I型糖尿病、II型糖尿病） ・シムリン（プラムリンチド）の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・シムリン（プラムリンチド）の販売チャネル・代理店・貿易業者・ディーラー分析 |
SYMLIN® (pramlintide acetate) injection is an anti-diabetic medication for use in patients with diabetes treated with insulin.
Scope of the Report:
The global Symlin (pramlintide) market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Symlin (pramlintide).
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Symlin (pramlintide) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Symlin (pramlintide) market by product type and applications/end industries.
Market Segment by Companies, this report covers
AstraZeneca
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
1.5ml pen-injector
2.7ml pen-injector
Market Segment by Applications, can be divided into
Type I diabetes
Type II diabetes
Table of Contents
1 Symlin (pramlintide) Market Overview
1.1 Product Overview and Scope of Symlin (pramlintide)
1.2 Classification of Symlin (pramlintide) by Types
1.2.1 Global Symlin (pramlintide) Revenue Comparison by Types (2019-2024)
1.2.2 Global Symlin (pramlintide) Revenue Market Share by Types in 2018
1.2.3 1.5ml pen-injector
1.2.4 2.7ml pen-injector
1.3 Global Symlin (pramlintide) Market by Application
1.3.1 Global Symlin (pramlintide) Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Type I diabetes
1.3.3 Type II diabetes
1.4 Global Symlin (pramlintide) Market by Regions
1.4.1 Global Symlin (pramlintide) Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Symlin (pramlintide) Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Symlin (pramlintide) Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Symlin (pramlintide) Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Symlin (pramlintide) Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Symlin (pramlintide) Status and Prospect (2014-2024)
1.5 Global Market Size of Symlin (pramlintide) (2014-2024)
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 Business Overview
2.1.2 Symlin (pramlintide) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AstraZeneca Symlin (pramlintide) Revenue, Gross Margin and Market Share (2017-2018)
3 Global Symlin (pramlintide) Market Competition, by Players
3.1 Global Symlin (pramlintide) Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Symlin (pramlintide) Players Market Share
3.2.2 Top 10 Symlin (pramlintide) Players Market Share
3.3 Market Competition Trend
4 Global Symlin (pramlintide) Market Size by Regions
4.1 Global Symlin (pramlintide) Revenue and Market Share by Regions
4.2 North America Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
4.3 Europe Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
4.5 South America Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
5 North America Symlin (pramlintide) Revenue by Countries
5.1 North America Symlin (pramlintide) Revenue by Countries (2014-2019)
5.2 USA Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
5.3 Canada Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
5.4 Mexico Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
6 Europe Symlin (pramlintide) Revenue by Countries
6.1 Europe Symlin (pramlintide) Revenue by Countries (2014-2019)
6.2 Germany Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
6.3 UK Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
6.4 France Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
6.5 Russia Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
6.6 Italy Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Symlin (pramlintide) Revenue by Countries
7.1 Asia-Pacific Symlin (pramlintide) Revenue by Countries (2014-2019)
7.2 China Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
7.3 Japan Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
7.4 Korea Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
7.5 India Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
8 South America Symlin (pramlintide) Revenue by Countries
8.1 South America Symlin (pramlintide) Revenue by Countries (2014-2019)
8.2 Brazil Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
8.3 Argentina Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
8.4 Colombia Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Symlin (pramlintide) by Countries
9.1 Middle East and Africa Symlin (pramlintide) Revenue by Countries (2014-2019)
9.2 Saudi Arabia Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
9.3 UAE Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
9.4 Egypt Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
9.5 Nigeria Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
9.6 South Africa Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
10 Global Symlin (pramlintide) Market Segment by Type
10.1 Global Symlin (pramlintide) Revenue and Market Share by Type (2014-2019)
10.2 Global Symlin (pramlintide) Market Forecast by Type (2019-2024)
10.3 1.5ml pen-injector Revenue Growth Rate (2014-2024)
10.4 2.7ml pen-injector Revenue Growth Rate (2014-2024)
11 Global Symlin (pramlintide) Market Segment by Application
11.1 Global Symlin (pramlintide) Revenue Market Share by Application (2014-2019)
11.2 Symlin (pramlintide) Market Forecast by Application (2019-2024)
11.3 Type I diabetes Revenue Growth (2014-2019)
11.4 Type II diabetes Revenue Growth (2014-2019)
12 Global Symlin (pramlintide) Market Size Forecast (2019-2024)
12.1 Global Symlin (pramlintide) Market Size Forecast (2019-2024)
12.2 Global Symlin (pramlintide) Market Forecast by Regions (2019-2024)
12.3 North America Symlin (pramlintide) Revenue Market Forecast (2019-2024)
12.4 Europe Symlin (pramlintide) Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Symlin (pramlintide) Revenue Market Forecast (2019-2024)
12.6 South America Symlin (pramlintide) Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Symlin (pramlintide) Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Symlin (pramlintide) Picture
Table Product Specifications of Symlin (pramlintide)
Table Global Symlin (pramlintide) and Revenue (Million USD) Market Split by Product Type
Figure Global Symlin (pramlintide) Revenue Market Share by Types in 2018
Figure 1.5ml pen-injector Picture
Figure 2.7ml pen-injector Picture
Table Global Symlin (pramlintide) Revenue (Million USD) by Application (2014-2024)
Figure Symlin (pramlintide) Revenue Market Share by Applications in 2018
Figure Type I diabetes Picture
Figure Type II diabetes Picture
Table Global Market Symlin (pramlintide) Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2014-2024)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Symlin (pramlintide) Type and Applications
Table AstraZeneca Symlin (pramlintide) Revenue, Gross Margin and Market Share (2017-2018)
Table Global Symlin (pramlintide) Revenue (Million USD) by Players (2014-2019)
Table Global Symlin (pramlintide) Revenue Share by Players (2014-2019)
Figure Global Symlin (pramlintide) Revenue Share by Players in 2017
Figure Global Symlin (pramlintide) Revenue Share by Players in 2018
Figure Global Top 5 Players Symlin (pramlintide) Revenue Market Share in 2018
Figure Global Top 10 Players Symlin (pramlintide) Revenue Market Share in 2018
Figure Global Symlin (pramlintide) Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Symlin (pramlintide) Revenue (Million USD) by Regions (2014-2019)
Table Global Symlin (pramlintide) Revenue Market Share by Regions (2014-2019)
Figure Global Symlin (pramlintide) Revenue Market Share by Regions (2014-2019)
Figure Global Symlin (pramlintide) Revenue Market Share by Regions in 2018
Figure North America Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Europe Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure South America Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Table North America Symlin (pramlintide) Revenue by Countries (2014-2019)
Table North America Symlin (pramlintide) Revenue Market Share by Countries (2014-2019)
Figure North America Symlin (pramlintide) Revenue Market Share by Countries (2014-2019)
Figure North America Symlin (pramlintide) Revenue Market Share by Countries in 2018
Figure USA Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Canada Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Mexico Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Table Europe Symlin (pramlintide) Revenue (Million USD) by Countries (2014-2019)
Figure Europe Symlin (pramlintide) Revenue Market Share by Countries (2014-2019)
Figure Europe Symlin (pramlintide) Revenue Market Share by Countries in 2018
Figure Germany Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure UK Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure France Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Russia Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Italy Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Symlin (pramlintide) Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Symlin (pramlintide) Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Symlin (pramlintide) Revenue Market Share by Countries in 2018
Figure China Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Japan Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Korea Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure India Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Table South America Symlin (pramlintide) Revenue by Countries (2014-2019)
Table South America Symlin (pramlintide) Revenue Market Share by Countries (2014-2019)
Figure South America Symlin (pramlintide) Revenue Market Share by Countries (2014-2019)
Figure South America Symlin (pramlintide) Revenue Market Share by Countries in 2018
Figure Brazil Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Argentina Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Colombia Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Symlin (pramlintide) Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Symlin (pramlintide) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Symlin (pramlintide) Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Symlin (pramlintide) Revenue Market Share by Countries in 2018
Figure Saudi Arabia Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure UAE Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Egypt Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure Nigeria Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Figure South Africa Symlin (pramlintide) Revenue and Growth Rate (2014-2019)
Table Global Symlin (pramlintide) Revenue (Million USD) by Type (2014-2019)
Table Global Symlin (pramlintide) Revenue Share by Type (2014-2019)
Figure Global Symlin (pramlintide) Revenue Share by Type (2014-2019)
Figure Global Symlin (pramlintide) Revenue Share by Type in 2019
Table Global Symlin (pramlintide) Revenue Forecast by Type (2019-2024)
Figure Global Symlin (pramlintide) Market Share Forecast by Type (2019-2024)
Figure Global 1.5ml pen-injector Revenue Growth Rate (2014-2019)
Figure Global 2.7ml pen-injector Revenue Growth Rate (2014-2019)
Table Global Symlin (pramlintide) Revenue by Application (2014-2019)
Table Global Symlin (pramlintide) Revenue Share by Application (2014-2019)
Figure Global Symlin (pramlintide) Revenue Share by Application (2014-2019)
Figure Global Symlin (pramlintide) Revenue Share by Application in 2019
Table Global Symlin (pramlintide) Revenue Forecast by Application (2019-2024)
Figure Global Symlin (pramlintide) Market Share Forecast by Application (2019-2024)
Figure Global Type I diabetes Revenue Growth Rate (2014-2019)
Figure Global Type II diabetes Revenue Growth Rate (2014-2019)
Figure Global Symlin (pramlintide) Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Symlin (pramlintide) Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Symlin (pramlintide) Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Symlin (pramlintide) Revenue Market Forecast (2019-2024)
Figure Europe Symlin (pramlintide) Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Symlin (pramlintide) Revenue Market Forecast (2019-2024)
Figure South America Symlin (pramlintide) Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Symlin (pramlintide) Revenue Market Forecast (2019-2024)
PoEインジェクター市場：世界及び中国市場分析・予測（～2024年） POE Injector Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global POE Injector industry with a focus on the Chinese market. The report provides key statistics on the market status of the POE Injector manufacturers and is a valuable…- CTコントラストインジェクター市場：世界及び中国市場分析・予測（～2024年） CT Contrast Injector Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global CT Contrast Injector industry with a focus on the Chinese market. The report provides key statistics on the market status of the CT Contrast Injector manufac…
- 車両燃料噴射装置市場：世界及び中国市場分析・予測（～2024年） Vehicle Fuel Injector Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Vehicle Fuel Injector industry with a focus on the Chinese market. The report provides key statistics on the market status of the Vehicle Fuel Injector manu…
- 高圧CTコントラストインジェクター市場：世界及び中国市場分析・予測（～2024年） High Pressure CT Contrast Injector Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global High Pressure CT Contrast Injector industry with a focus on the Chinese market. The report provides key statistics on the market status of the …
- 世界の放射性医薬品インジェクター市場予測（～2024年）：メーカー別、地域別、種類・用途別 Automatic Injector is used to inject radiopharmaceuticals into patients to ensure the safety and dose accuracy. Scope of the Report: The worldwide market for Radiopharmaceutical Injector is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx…